BRUSSELS, April 25 (Reuters) - Belgium-based Arseus , the worlds biggest supplier of ingredients to pharmacists so they can mix up their own versions of drugs, bought U.S.-based Freedom Pharmaceuticals for an undisclosed sum, it said on Thursday.
The acquisition strengthens its global position in the market for drug compounding, where pharmacists assemble medicines themselves specifically tailored to the needs of their customers.
Arseus said in a statement that it paid 5.5 times EBITDA for Freedom Pharmaceuticals, which expects to achieve turnover of about $25 million in 2013.
(Reporting By Ben Deighton, Editing By Ethan Bilby) Keywords: ARSEUS ACQUISITION/
(firstname.lastname@example.org)(+32 2287 6811)(Reuters Messaging: rm://email@example.com)
Copyright Thomson Reuters 2013. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.